Edwin A. Cohen
Founder at Generic Pharmaceutical Industry Association
Profile
Edwin A.
Cohen is the founder of Ikano Therapeutics, Inc. (1998), Barr Laboratories, Inc. (1970), Davis-Edwards Pharmacal Corp.
(1959), Intranasal Therapeutics, Inc. (1998), and Summit Biosciences, Inc. (2008).
He held the title of Chairman & Chief Executive Officer at Barr Laboratories, Inc. and Intranasal Therapeutics, Inc., and the title of Co-Chairman & Chief Executive Officer at Summit Biosciences, Inc. Mr. Cohen is also the founder of National Association of Pharmaceutical Manufacturers, Generic Pharmaceutical Industry Association.
Currently, he is a Trustee at Fordham University since 1999.
Edwin A. Cohen active positions
Companies | Position | Start |
---|---|---|
Generic Pharmaceutical Industry Association | Founder | - |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | Director/Board Member | 2013-07-29 |
Former positions of Edwin A. Cohen
Companies | Position | End |
---|---|---|
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ikano Therapeutics Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative therapeutics, with an emphasis on products treating disorders related to the central nervous system (CNS) for which there is proven, unsatisfied consumer need. They currently have two products in its clinical pipeline, with and others in formulation or preclinical development. Its goal is to become a leader in the field of specialty pharmaceuticals by applying its formulation expertise across a broad range of therapeutic areas to create new and differentiated products that improve safety, efficacy and convenience for patients, caregivers and health care professionals. ITI's fully integrated drug delivery platform combines proprietary formulation research, clinical and regulatory development, specialized delivery systems, clinical manufacturing and packaging. These capabilities and expertise enable them to develop its products efficiently and cost effectively. They intend to commercialize these products by marketing them themselves or partnering them with other companies. Its senior management team collectively has more than 100 years of experience in the pharmaceutical industry and extensive experience with development-stage companies. ITI supplements its own internal expertise with a variety of outside expert consultants, academic and industry and makes strategic use of outsourcing for development and commercial manufacturing. | Founder | 2011-01-17 |
Intranasal Therapeutics, Inc. | Founder | 2007-12-31 |
Davis-Edwards Pharmacal Corp. | Founder | 1969-12-31 |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Founder | - |
Summit Biosciences, Inc.
Summit Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Summit Biosciences, Inc. develops, manufactures, and commercializes nasal spray drug products. Its services include formulation development, contract manufacturing of commercial and clinical products, spray characterization, and analytical development and validation. The company was founded by Edwin A. Cohen in 2008 and is headquartered in Lexington, KY. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
Ikano Therapeutics, Inc.
Ikano Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ikano Therapeutics Inc. (ITI) is a specialty pharmaceutical company focused on developing innovative therapeutics, with an emphasis on products treating disorders related to the central nervous system (CNS) for which there is proven, unsatisfied consumer need. They currently have two products in its clinical pipeline, with and others in formulation or preclinical development. Its goal is to become a leader in the field of specialty pharmaceuticals by applying its formulation expertise across a broad range of therapeutic areas to create new and differentiated products that improve safety, efficacy and convenience for patients, caregivers and health care professionals. ITI's fully integrated drug delivery platform combines proprietary formulation research, clinical and regulatory development, specialized delivery systems, clinical manufacturing and packaging. These capabilities and expertise enable them to develop its products efficiently and cost effectively. They intend to commercialize these products by marketing them themselves or partnering them with other companies. Its senior management team collectively has more than 100 years of experience in the pharmaceutical industry and extensive experience with development-stage companies. ITI supplements its own internal expertise with a variety of outside expert consultants, academic and industry and makes strategic use of outsourcing for development and commercial manufacturing. | Health Technology |
Davis-Edwards Pharmacal Corp. | |
National Association of Pharmaceutical Manufacturers | |
Summit Biosciences, Inc.
Summit Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Summit Biosciences, Inc. develops, manufactures, and commercializes nasal spray drug products. Its services include formulation development, contract manufacturing of commercial and clinical products, spray characterization, and analytical development and validation. The company was founded by Edwin A. Cohen in 2008 and is headquartered in Lexington, KY. | Health Technology |
Intranasal Therapeutics, Inc. | |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Barr Laboratories, Inc. develops and markets generic pharmaceuticals. The company was founded by Edwin A. Cohen in 1970 and is headquartered in Montvale, NJ. | Health Technology |
Generic Pharmaceutical Industry Association |
- Stock Market
- Insiders
- Edwin A. Cohen